XML 26 R79.htm IDEA: XBRL DOCUMENT v3.2.0.727
Supplemental Consolidating Financial Statements - Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jul. 25, 2015
Jul. 26, 2014
Jul. 27, 2013
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities $ 141,900 $ 84,185 $ 106,744
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired (31,909) (17,088) (330,291)
Capital expenditures (102,997) (89,136) (64,650)
Proceeds from sale of assets 9,392 15,407 5,827
Return of capital from subsidiaries 0 0 0
Investment in subsidiaries 0 0 0
Other investing activities (538) (303) 60
Changes in restricted cash (4,000) 0 0
Net cash used in investing activities (130,052) (91,120) (389,054)
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance) 0 0 93,825
Proceeds from borrowings on senior credit agreement, including term loan 535,750 502,000 529,500
Principal payments on senior credit agreement, including term loan (467,563) (495,813) (358,625)
Debt issuance costs (3,854) 0 (6,739)
Repurchases of common stock (87,146) (9,999) (15,203)
Exercise of stock options 8,922 14,568 5,253
Restricted stock tax withholdings (4,711) (3,781) (884)
Excess tax benefit from share-based awards 8,371 3,025 1,283
Net cash (used in) provided by financing activities (1,000) (1,000) (74)
Intercompany funding 0 0 0
Receipt of capital contributions, net 0    
Net cash (used in) provided by financing activities (11,231) 9,000 248,336
Net increase (decrease) in cash and equivalents 617 2,065 (33,974)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 20,672 18,607 52,581
CASH AND EQUIVALENTS AT END OF PERIOD 21,289 20,672 18,607
Parent      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities 3,805 7,199 6,952
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired 0 0 0
Capital expenditures (10,585) (8,541) (8,151)
Proceeds from sale of assets 8 0 0
Return of capital from subsidiaries 0 0 0
Investment in subsidiaries 0 0 0
Other investing activities (541) (303) 60
Changes in restricted cash 0    
Net cash used in investing activities (11,118) (8,844) (8,091)
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance)     0
Proceeds from borrowings on senior credit agreement, including term loan 535,750 502,000 529,500
Principal payments on senior credit agreement, including term loan (467,563) (495,813) (358,625)
Debt issuance costs (3,854)   (4,158)
Repurchases of common stock (87,146) (9,999) (15,203)
Exercise of stock options 8,922 14,568 5,253
Restricted stock tax withholdings (4,711) (3,781) (884)
Excess tax benefit from share-based awards 8,371 3,025 1,283
Net cash (used in) provided by financing activities 0 0 0
Intercompany funding 17,544 (8,355) (156,027)
Receipt of capital contributions, net 0    
Net cash (used in) provided by financing activities 7,313 1,645 1,139
Net increase (decrease) in cash and equivalents 0 0 0
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 0 0 0
CASH AND EQUIVALENTS AT END OF PERIOD 0 0 0
Issuer      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (12,703) (12,242) (9,612)
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired 0 0 0
Capital expenditures 0 0 0
Proceeds from sale of assets 0 0 0
Return of capital from subsidiaries 2,394 683 1,816
Investment in subsidiaries (409,414) (9,235) (2,600)
Other investing activities 0 0 0
Changes in restricted cash 0    
Net cash used in investing activities (407,020) (8,552) (784)
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance)     93,825
Proceeds from borrowings on senior credit agreement, including term loan 0 0 0
Principal payments on senior credit agreement, including term loan 0 0 0
Debt issuance costs 0   (2,581)
Repurchases of common stock 0 0 0
Exercise of stock options 0 0 0
Restricted stock tax withholdings 0 0 0
Excess tax benefit from share-based awards 0 0 0
Net cash (used in) provided by financing activities 0 0 0
Intercompany funding 419,723 20,794 (80,848)
Receipt of capital contributions, net 0    
Net cash (used in) provided by financing activities 419,723 20,794 10,396
Net increase (decrease) in cash and equivalents 0 0 0
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 0 0 0
CASH AND EQUIVALENTS AT END OF PERIOD 0 0 0
Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities 151,419 93,898 112,176
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired (31,909) (16,388) (330,291)
Capital expenditures (83,024) (72,962) (51,647)
Proceeds from sale of assets 9,375 12,146 5,770
Return of capital from subsidiaries 0 0 0
Investment in subsidiaries (385) (785) 0
Other investing activities 3 0 0
Changes in restricted cash 0    
Net cash used in investing activities (105,940) (77,989) (376,168)
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance)     0
Proceeds from borrowings on senior credit agreement, including term loan 0 0 0
Principal payments on senior credit agreement, including term loan 0 0 0
Debt issuance costs 0   0
Repurchases of common stock 0 0 0
Exercise of stock options 0 0 0
Restricted stock tax withholdings 0 0 0
Excess tax benefit from share-based awards 0 0 0
Net cash (used in) provided by financing activities (1,000) (1,000) (74)
Intercompany funding (435,732) (13,336) 230,669
Receipt of capital contributions, net 392,029    
Net cash (used in) provided by financing activities (44,703) (14,336) 230,595
Net increase (decrease) in cash and equivalents 776 1,573 (33,397)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 19,739 18,166 51,563
CASH AND EQUIVALENTS AT END OF PERIOD 20,515 19,739 18,166
Non- Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (621) (4,670) (2,772)
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired 0 (700) 0
Capital expenditures (9,388) (7,633) (4,852)
Proceeds from sale of assets 9 3,261 57
Return of capital from subsidiaries 0 0 0
Investment in subsidiaries 0 0 0
Other investing activities 0 0 0
Changes in restricted cash (4,000)    
Net cash used in investing activities (13,379) (5,072) (4,795)
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance)     0
Proceeds from borrowings on senior credit agreement, including term loan 0 0 0
Principal payments on senior credit agreement, including term loan 0 0 0
Debt issuance costs 0   0
Repurchases of common stock 0 0 0
Exercise of stock options 0 0 0
Restricted stock tax withholdings 0 0 0
Excess tax benefit from share-based awards 0 0 0
Net cash (used in) provided by financing activities 0 0 0
Intercompany funding (1,535) 10,234 6,990
Receipt of capital contributions, net 15,376    
Net cash (used in) provided by financing activities 13,841 10,234 6,990
Net increase (decrease) in cash and equivalents (159) 492 (577)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 933 441 1,018
CASH AND EQUIVALENTS AT END OF PERIOD 774 933 441
Eliminations and Reclassifications      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities 0 0 0
INVESTING ACTIVITIES:      
Cash paid for acquisitions, net of cash acquired 0 0 0
Capital expenditures 0 0 0
Proceeds from sale of assets 0 0 0
Return of capital from subsidiaries (2,394) (683) (1,816)
Investment in subsidiaries 409,799 10,020 2,600
Other investing activities 0 0 0
Changes in restricted cash 0    
Net cash used in investing activities 407,405 9,337 784
FINANCING ACTIVITIES:      
Proceeds from issuance of 7.125% senior subordinated notes due 2021 (including $3.8 million premium on fiscal 2013 issuance)     0
Proceeds from borrowings on senior credit agreement, including term loan 0 0 0
Principal payments on senior credit agreement, including term loan 0 0 0
Debt issuance costs 0   0
Repurchases of common stock 0 0 0
Exercise of stock options 0 0 0
Restricted stock tax withholdings 0 0 0
Excess tax benefit from share-based awards 0 0 0
Net cash (used in) provided by financing activities 0 0 0
Intercompany funding 0 (9,337) (784)
Receipt of capital contributions, net (407,405)    
Net cash (used in) provided by financing activities (407,405) (9,337) (784)
Net increase (decrease) in cash and equivalents 0 0 0
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 0 0 0
CASH AND EQUIVALENTS AT END OF PERIOD $ 0 $ 0 $ 0